| GlaxoSmithKline AG - Benlysta, Lösung zur subkutanen Injektion (Autoinjektor) |
| 66585 | | 01 | | Benlysta | | Lösung zur subkutanen Injektion (Autoinjektor) | | L04AG04 | | | | 29.06.2018 | | |
|
| Composition |
| belimumabum 200 mg, natrii chloridum, arginini hydrochloridum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Lösung zur subkutanen Injektion (Autoinjektor) | | | | | | | | Active Agent | Dose |
|---|
| Belimumabum | 200 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Belimumabum | 200 mg |
| | | | Inactive agents |
|---|
| Arginine Hydrochloride | | Histidin Hydrochloride Monohydrate | | Histidine | | Sodium Chloride | | Polysorbatum 80 |
| |
|
|
